ConductScience.org, home

Paper2416628

Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.

Steinberg WM and 6 others. Gastroenterology, 1986. Cited by 236 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Papers, record 2416628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2416628

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas.
PubMed
Journal
Gastroenterology
PubMed
Year
1986
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
236
iCite
Relative citation ratio, by iCite
7.36
iCite
Revised in PubMed
2022-04-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steinberg WMW M
2Gelfand RR
3Anderson KKK K
4Glenn JJ
5Kurtzman SHS H
6Sindelar WFW F
7Toskes PPP P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Antibodies, MonoclonalMajor topic
Antigens, NeoplasmMajor topic
Carcinoembryonic AntigenMajor topic
EpitopesMajor topic
Pancreatic NeoplasmsMajor topic
Antigens, Tumor-Associated, Carbohydrate
Humans
Radioimmunoassay

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.

PMIDTitleJournalYearIn PapersSource
42824914ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer.Front Oncol2026https://conductscience.org/library/papers/42824914PubMed
42738303Serum SAMD9 as a Potential Prognostic Biomarker for Pancreatic Cancer.Cancers (Basel)2026https://conductscience.org/library/papers/42738303PubMed
42587626A Clinical Score to Identify Individuals at High Risk of Pancreatic Cancer in the General Population.Diagnostics (Basel)2026https://conductscience.org/library/papers/42587626PubMed
41463153CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.Cancers (Basel)2025https://conductscience.org/library/papers/41463153PubMed
39849359High serum CA19-9 predicts severe cholecystitis in calculous cholecystitis patients.BMC Gastroenterol2025https://conductscience.org/library/papers/39849359PubMed
39529638Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples.Gastro Hep Adv2024https://conductscience.org/library/papers/39529638PubMed
38493006Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Blood Rev2024https://conductscience.org/library/papers/38493006PubMed
37373743CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.J Clin Med2023https://conductscience.org/library/papers/37373743PubMed
35277545Clinical features and prognostic impact of asymptomatic pancreatic cancer.Sci Rep2022https://conductscience.org/library/papers/35277545PubMed
33333055Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.Gastroenterology2021https://conductscience.org/library/papers/33333055PubMed
32089746Refining Cancer Management Using Integrated Liquid Biopsy.Theranostics2020https://conductscience.org/library/papers/32089746PubMed
31221853The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.Science2019https://conductscience.org/library/papers/31221853PubMed
30766566comparative study of carbohydrate antigen 19-9 in sickle cell disease subjects and controls in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.Afr Health Sci2018https://conductscience.org/library/papers/30766566PubMed
29151947Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.J Cancer2017https://conductscience.org/library/papers/29151947PubMed
28536479Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.Sci Rep2017https://conductscience.org/library/papers/28536479PubMed
28511463Unusually High Serum Levels of CA 19-9 in an Ovarian Tumour: Malignant or Benign?J Clin Diagn Res2017https://conductscience.org/library/papers/28511463PubMed
28367245The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study.J Cancer2017https://conductscience.org/library/papers/28367245PubMed
27053885Clinical significance of CA19-9 in diagnosis of digestive tract tumors.World J Gastroenterol1997https://conductscience.org/library/papers/27053885PubMed
25580353The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curative resection.J Gastric Cancer2014https://conductscience.org/library/papers/25580353PubMed
25191515
Clinical evaluation, imaging studies, indications for cytologic study and preprocedural requirements for duct brushing studies and pancreatic fine-needle aspiration: The Papanicolaou Society of Cytopathology Guidelines.
Cytojournal2014https://conductscience.org/library/papers/25191515PubMed

See all 53 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2416628

GET https://conductscience.org/api/papers/v1/2416628/cited_by?page=2